• Exchange: KOSDAQ
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Hwail Pharm Co Ltd

+ Add to Watchlist

061250:KS

7,210 KRW 80 1.12%

As of 02:10:00 ET on 07/25/2014.

Snapshot for Hwail Pharm Co Ltd (061250)

Open: 7,160 Day's Range: 7,060 - 7,280 Volume: 223,871
Previous Close: 7,130 52wk Range: 4,970 - 11,450 1-Yr Rtn: -29.14%

Stock Chart for 061250

No chart data available.
  • 061250:KS 7,210
  • 1D
  • 1M
  • 1Y
7,130
Interactive 061250 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 061250

Current P/E Ratio (ttm) 22.8889
Estimated P/E(12/2014) -
Relative P/E vs. KOSPI 0.1708
Earnings Per Share (ttm) 315.0000
Est. EPS (12/2014) 455.7000
Est. PEG Ratio -
Market Cap (M KRW) 103,903.01
Shares Outstanding (M) 14.41
30 Day Average Volume 96,911
Price/Book (mrq) 1.1283
Price/Sale (ttm) 1.0336
Dividend Indicated Gross Yield 1.39%
Cash Dividend (KRW) 100.0000
Dividend Ex-Date 12/27/2013
5 Year Dividend Growth 0.00%
Next Earnings Announcement 08/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 061250

  • Revenue
  • Net Income (M/KRW)
  • Profit Margin (%)

Company Profile & Key Executives for 061250

Hwail Pharm Co., Ltd. produces pharmaceutical raw materials. The Company's products include Talniflumate, Alibendol, and Oxatomide. Hwail supplies these materials to companies dealing with finished pharmaceutical products.

Lee Joung-KyuChairman/Co-Rep DirectorCho Joong-MyungChairman/Co-Rep Director
Park Pil-JunPresident/Co-Rep DirectorKo Jae-KyuPresident
More Company Profile & Key Executives for 061250

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil